| Characteristic |
Booster Status
|
p-value2 | ||
|---|---|---|---|---|
| All Participants (N=843,208)1 | Booster N = 758,1181 |
No Booster N = 85,0901 |
||
| Age — yr | 68.5 ± 10.6 | 68.9 ± 10.5 | 64.8 ± 10.9 | <0.001 |
| Female sex — no. (%) | <0.001 | |||
| Female | 448,272 (53%) | 400,300 (53%) | 47,972 (56%) | |
| Male | 394,936 (47%) | 357,818 (47%) | 37,118 (44%) | |
| Diabetes | 244,746 (29%) | 220,959 (29%) | 23,787 (28%) | <0.001 |
| Chronic obstructive pulmonary disease | 41,449 (4.9%) | 37,291 (4.9%) | 4,158 (4.9%) | 0.7 |
| Asthma | 51,360 (6.1%) | 46,198 (6.1%) | 5,162 (6.1%) | 0.8 |
| Chronic kidney failure | 51,636 (6.1%) | 47,187 (6.2%) | 4,449 (5.2%) | <0.001 |
| Hypertension | 391,654 (46%) | 358,517 (47%) | 33,137 (39%) | <0.001 |
| Ischemic heart disease | 142,742 (17%) | 131,058 (17%) | 11,684 (14%) | <0.001 |
| Chronic heart failure | 37,297 (4.4%) | 33,524 (4.4%) | 3,773 (4.4%) | 0.9 |
| Obesity | 278,097 (33%) | 249,152 (33%) | 28,945 (34%) | <0.001 |
| History of smoking | 348,654 (41%) | 314,226 (41%) | 34,428 (40%) | <0.001 |
| 1 Mean ± SD; n (%) | ||||
| 2 Wilcoxon rank sum test; Pearson’s Chi-squared test | ||||